#151051

Anti-Testosterone [3T16] mAb

Cat. #151051

Anti-Testosterone [3T16] mAb

Cat. #: 151051

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 1-2 weeks

Target: Testosterone-3-(O-carboxymethyl)oxime)

Class: Monoclonal

Application: ELISA ; RIA

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Dennis Wang

Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY

  • Name: Anti-Testosterone [3T16] mAb
  • Clone: 3T16
  • Tool type ecom: Antibodies
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 33-36
  • Strain: Balb/c
  • Reactivity: Human
  • Host: Mouse
  • Application: ELISA ; RIA
  • Description: 3T16 can be used for detecting and measuring testosterone levels in serum and tissue.
  • Immunogen: Testosterone-3-(O-carboxymethyl)oxime coupled to bovine serum albumin
  • Isotype: IgG1
  • Myeloma used: P3/NS1/1-Ag4.1
  • Recommended controls: A431 cells or HeLa

Target Details

  • Target: Testosterone-3-(O-carboxymethyl)oxime)
  • Molecular weight: 33-36
  • Tissue cell line specificity: A431 cells or HeLa
  • Target background: Testosterone is the major androgen steroid hormone and has a role in reproduction and the development of male secondary sex characteristics.

Applications

  • Application: ELISA ; RIA

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Shipping at 4° C

References

  • Fantl et al. 1983. J Steroid Biochem. 19(5):1605-10. PMID: 6645496.
  • Characterisation of monoclonal antibodies raised against testosterone.